Go Ad-Free
    My Alerts
    Budget Express 2026

    co-presented by

    • JIO BlackRock

    ASSOCIATE SPONSORS

    • Sunteck
    • SBI
    HomeNewsBusinessEarningsParabolic Drugs Q3 PAT up 33.2% at Rs 12.5 cr

    Parabolic Drugs Q3 PAT up 33.2% at Rs 12.5 cr

    Parabolic Drugs Q3 revenue was up 29.8% at Rs 151.5 crore versus Rs 116.7 crore, YoY. Its PAT was up 33.2% at Rs 12.5 crore versus Rs 9.4 crore, YoY.

    February 02, 2011 / 10:52 IST

    Parabolic Drugs Q3 revenue was up 29.8% at Rs 151.5 crore versus Rs 116.7 crore, YoY.  Its PAT was up 33.2% at Rs 12.5 crore versus Rs 9.4 crore, YoY.

    Its EBITDA margin was 20.9% versus 20.5%, YoY.

    The company's consumption of raw material was up 45.6% at Rs 124.6 crore versus Rs 85.6 crore, YoY.

    first published: Feb 2, 2011 09:13 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347